Pathobiological implications of MUC16 expression in pancreatic cancer.
MUC16 (CA125) belongs to a family of high-molecular weight O-glycosylated proteins known as mucins. While MUC16 is well known as a biomarker in ovarian cancer, its expression pattern in pancreatic cancer (PC), the fourth leading cause of cancer related deaths in the United States, remains unknown. T...
Main Authors: | Dhanya Haridas, Subhankar Chakraborty, Moorthy P Ponnusamy, Imayavaramban Lakshmanan, Satyanarayana Rachagani, Eric Cruz, Sushil Kumar, Srustidhar Das, Subodh M Lele, Judy M Anderson, Uwe A Wittel, Michael A Hollingsworth, Surinder K Batra |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3204976?pdf=render |
Similar Items
-
MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
by: Partha Mukhopadhyay, et al.
Published: (2013-01-01) -
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
by: Rachagani Satyanarayana, et al.
Published: (2012-10-01) -
Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.
by: Sukhwinder Kaur, et al.
Published: (2014-01-01) -
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
by: Abhijit Aithal, et al.
Published: (2018-01-01) -
Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.
by: Hiroaki Shibahara, et al.
Published: (2014-01-01)